Figure 2From: The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancerKaplan Meier survival analysis of the distant metastases-free survival of patients. (A) Patients were grouped according to CRIP1 expression into negative (0) and positive (classified 1+ to 3+) groups. (B) Only patients with HER2-positive tumors were stratified according to their CRIP1 expression (negative vs. positive).Back to article page